
PeptiSlimRetatrutide
Ordered Retatrutide from PeptiSlim? Mail in a sample (US only) and let us test it.
Test my supplyPeptiSlim Retatrutide's caveats are two purity misses, including 99.02%, plus one -40% fill miss; most other purity-focus checks clear. Later tests look steadier, while batch identifiers remain uneven.
Corporate and web-infrastructure records point to a China/Hong Kong PeptiSlim cluster with unresolved ownership and a linked Lilipetide surface. The report also traces an AU/BioSynteq COA system whose independent-lab claim fails file and origin checks.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including PeptiSlim rows.
Cancel anytime
Ordered Retatrutide from PeptiSlim? Mail in a sample (US only) and let us test it.
Test my supplyAbout PeptiSlim test results from Finnrick
PeptiSlim is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 75 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible PeptiSlim peptides in this dataset are Tirzepatide (32 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 75 recent tests.
Ordered Retatrutide from PeptiSlim? Mail in a sample (US only) and let us test it.
Test my supply